MED vs CSV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

MED

43.7
AI Score
VS
MED Wins

CSV

26.8
AI Score

Investment Advisor Scores

MED

44score
Recommendation
HOLD

CSV

27score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MED CSV Winner
Revenue 152.43M 209.07M CSV
Net Income -5.22M 25.76M CSV
Gross Margin 69.0% 35.2% MED
Net Margin -3.4% 12.3% CSV
Operating Income -7.62M 49.23M CSV
ROE -2.7% 9.2% CSV
ROA -2.0% 1.9% CSV
Total Assets 260.40M 1.37B CSV
Cash 71.91M 2.55M MED
Current Ratio 4.86 1.46 MED
Free Cash Flow -108,000 13.23M CSV

Relative Price Performance (Last 90 Days)

MED 1M: +3.9% · 3M: +1.0% CSV 1M: -3.5% · 3M: -18.0%

Current Technical Phase

MED

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.4% over 20 days), RSI 53

RSI (14): 52.8 · Price: $12.04

CSV

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.8%), weak momentum, RSI 35

RSI (14): 35.3 · Price: $32.52

Fundamentals Snapshot

Metric MED CSV
Market Cap
Forward P/E -43.0 8.9
Trailing P/E 11.5
Revenue (TTM)
Revenue Growth -0.3% 0.0%
Gross Margin 0.7% 0.4%
Operating Margin -0.1% 0.2%
EPS -2.31 2.79
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, MED is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.